Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038649
Status:
TERMINATED
Last Update Posted:
2018-10-09
First Post:
2002-06-03
Brief Title:
Therapy of Early Chronic Phase CML With Higher-Dose Gleevec Alpha Interferon and Low-Dose Ara-C
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelogenous Leukemia Chronic Chronic Phase |